Every monsoon and winter, hospitals see a rise in babies struggling with severe cough, breathing trouble, or symptoms that seem like an upper respiratory tract infection or pneumonia. Many parents ...

• RSV is the leading cause of infant hospitalization in the U.S. • Health officials urge vaccination for pregnant women, seniors, and people with medical risks. • Cases are climbing nationwide as flu ...

In response to the global burden of severe respiratory syncytial virus (RSV) disease among infants, the World Health Organisation (WHO) has released its first position paper recommending the global ...

Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...

Coughing, sneezing and a runny nose: You might think it is yet another cold, but if your baby is under 2 years old, it could very well be respiratory syncytial virus (RSV). RSV is a virus infecting ...

Respiratory syncytial virus (RSV)–associated hospitalization rates among infants in the United States were significantly lower in the first year when prevention products were widely available, based ...

RSV prevention products led to a significant reduction in hospitalization rates for infants aged 0 to 7 months during the 2024-2025 season. The maternal RSV vaccine and nirsevimab were key ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...